1910
Senior computational chemist role at an AI-native biotechnology company focused on AI-enabled drug discovery. The position supports development and application of advanced computational methods and infrastructure to drive small- and large-molecule therapeutic discovery across programs. The role involves scientific leadership and cross-disciplinary partnership to translate computational insights into drug development progress.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2018
1910 is an AI-native biotech company building multimodal, modality-agnostic AI infrastructure for pharmaceutical R&D. Its ITO™ platform integrates wet‑lab, computational, and proxy data to power predictive models and end‑to‑end workflows that help companies discover and reliably "drug the undruggable." 1910’s technology is designed to accelerate target selection, molecule design, and experimental decision‑making, reducing time and cost in the drug discovery pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1910.
1910 didn’t post a salary, so this is our estimate from similar listings.
Bucoda incorporates on July 5, 1910.
Sep 2, 2025
Senior Computational Chemist, Drug Discovery (UK)
SandboxAQ
Computational Chemist
Magnet Biomedicine
Research Advisor, Computational Chemistry
Eli Lilly and Company
Senior Computational Chemist (Drug Discovery & Generative AI) -CDI- F/M
Pierre Fabre Group
Computational Chemist
Ashland
Senior Computational Chemist
Corteva Agriscience